UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061905
Receipt number R000070837
Scientific Title Role of SPST in Improving the Social Life of People Living with HIV/AIDS
Date of disclosure of the study information 2026/06/15
Last modified on 2026/06/15 00:42:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Role of SPST in Improving the Social Life of People Living with HIV/AIDS

Acronym

SPST for Social Life of People Living with HIV/AIDS

Scientific Title

Role of SPST in Improving the Social Life of People Living with HIV/AIDS

Scientific Title:Acronym

SPST for Social Life of People Living with HIV/AIDS

Region

Africa


Condition

Condition

social maladjustment

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study investigated the effectiveness of Social Problem-Solving Therapy (SPST) on the social adjustment of people living with HIV/AIDS

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Social Maladjustment Scale

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

22 participants received the SPST intervention, which consists of 12 sessions, each lasting approximately 60 minutes.

Interventions/Control_2

The other 22 participants received a placebo and were active during the intervention, which also consists of 12 sessions, each lasting approximately 60 minutes.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <

Age-upper limit

55 years-old >

Gender

Male and Female

Key inclusion criteria

a) must be an HIV/AIDS outpatient,
b) must give consent to participate,
c) must have been socially maladjusted,
d) must have been diagnosed with HIV, and
e) must be resident in Nsukka, Enugu state, Nigeria

Key exclusion criteria

Those who did not meet up were excluded.

Target sample size

44


Research contact person

Name of lead principal investigator

1st name Moses
Middle name Onyemaechi
Last name Ede

Organization

University of Nigeria

Division name

University

Zip code

410001

Address

University of Nigeria

TEL

+2347066725165

Email

onyemaechi.moses@gmail.com


Public contact

Name of contact person

1st name Moses
Middle name Onyemaechi
Last name Ede

Organization

University of Nigeria

Division name

University

Zip code

410001

Address

University of Nigeria

TEL

+2347066725165

Homepage URL


Email

onyemaechi.moses@gmail.com


Sponsor or person

Institute

University of Nigeria

Institute

Department

Personal name



Funding Source

Organization

University of Nigeria

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Nigeria

Address

University of Nigeria

Tel

+2347066725165

Email

onyemaechi.moses@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 06 Month 15 Day


Related information

URL releasing protocol

No URL

Publication of results

Unpublished


Result

URL related to results and publications

No URL

Number of participants that the trial has enrolled

44

Results

Findings revealed that SPST significantly improved social adjustment among participants, while gender had no significant effect, and there was no interaction effect between SPST and gender.

Results date posted

2026 Year 06 Month 15 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Social maladjustment

Participant flow

22 participants in the intervention group and 22 participants in the comparison group

Adverse events

No adverse effect

Outcome measures

Social maladjustment scale

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 03 Month 27 Day

Date of IRB

2022 Year 06 Month 15 Day

Anticipated trial start date

2022 Year 09 Month 07 Day

Last follow-up date

2023 Year 03 Month 19 Day

Date of closure to data entry

2023 Year 05 Month 14 Day

Date trial data considered complete

2023 Year 07 Month 17 Day

Date analysis concluded

2023 Year 10 Month 25 Day


Other

Other related information



Management information

Registered date

2026 Year 06 Month 15 Day

Last modified on

2026 Year 06 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070837